Key Developments: Medistim ASA (MEDS.OL)

MEDS.OL on Oslo Stock Exchange

25.00NOK
21 Nov 2014
Price Change (% chg)

kr0.00 (+0.00%)
Prev Close
kr25.00
Open
kr25.00
Day's High
kr25.00
Day's Low
kr25.00
Volume
10,210
Avg. Vol
5,976
52-wk High
kr28.00
52-wk Low
kr20.20

Search Stocks

Latest Key Developments (Source: Significant Developments)

Medistim ASA's subsidiary Medistim Norge AS wins nationwide tender
Thursday, 6 Nov 2014 06:32am EST 

Medistim ASA:Says Medistims subsidiary Medistim Norge AS has won nationwide tender for breast implants.Says tender for breast implants was organized by HINAS (Helseforetakenes innkjopsservice AS).Says agreement with HINAS starts Jan. 1, 2015 and will last initially for 2 years, with the possibility of 2 years extension.Says agreement size is estimated to be 8 to 10 million Norwegian crowns per year.  Full Article

Chr Salvesen & Chr Thams Communications Aktieselskab to transfer its ownership of shares in Medistim ASA to Thams Invest AS
Wednesday, 9 Jul 2014 02:00am EDT 

Medistim ASA:Says Boards of Chr Salvesen & Chr Thams Communications Aktieselskab and the holding company Thams Invest AS decided to transfer ownership of its 1,862,500 shares in Medistim ASA from Chr Salvesen & Chr Thams Communications Aktieselskab to Thams Invest AS.Transaction is part of reorganization of business which was originally located in Chr Salvesen & Chr Thamshavn's Communications Aktieselskab.Transaction will be implemented in two steps.First there is demerger where Medistim shares will be transferred to sister company Salvesen & Thames Lokken AS.Thereafter a parent-subsidiary merger is performed, which moves the ownership of the Medistim shares to Thams Invest AS.Transactions are assumed done in the last half of Aug., after the creditor notification period is over.  Full Article

Medistim receives clearance from Russia for sale of VeriQ C
Wednesday, 25 Jun 2014 06:21am EDT 

Medistim ASA:Receives clearance from health authorities in Russia for sale of its product VeriQ C.VeriQ C is intraoperative systems for quality assessment used during coronary artery bypass grafting (CABG).Medistim has already obtained clearance from Food and Drug Administration in United States (FDA), CE certificate in Europe and clearance for sale in Japan and Canada.  Full Article

Medistim ASA proposes FY 2013 dividend of 0.80 Norwegian crown per share
Thursday, 20 Feb 2014 02:00am EST 

Medistim ASA:Says its Board suggests a dividend of 0.80 Norwegian crown per share for fiscal year 2013.  Full Article

Intertrade Shipping AS acquires 21 pct shares in Medistim ASA from subsidiary
Thursday, 28 Nov 2013 06:43am EST 

Medistim ASA:Says Intertrade Shipping AS has purchased 3,810,000 shares in Medistim from Flotemarken AS at 22 Norwegian crowns per share.Says Intertrade Shipping AS will after the transaction own 3,850,000 shares in Medistim, which constitutes 21 percent of its share capital.Says Flotemarken is a 100% owned subsidiary of Intertrade Shipping.Says Intertrade Shipping AS is 100% owned by Oyvin A. Broymer, Chairman of the Board of Directors of Medistim.  Full Article

Stenshagen Invest AS Acquires Shares in Medistim ASA
Friday, 20 Sep 2013 06:12am EDT 

Medistim ASA announced that Stenshagen Invest AS has acquired 1,338,463 shares in the Company. Prior to the transaction, Stenshagen Invest held no shares in Medistim.  Full Article

Queen Elizabeth Hospital Birmingham Adopts VeriQC from Medistim ASA
Monday, 22 Jul 2013 06:49am EDT 

Medistim ASA announced that the Queen Elizabeth Hospital Birmingham is adopting Medistim's model VeriQC, a system used for intraoperative quality assessment of coronary artery bypass grafting and that incorporates ultrasound imaging in addition to transit time flow measurement (TTFM). Financial details were not disclosed.  Full Article

Medistim ASA Updates on FY 2012 Dividend
Thursday, 25 Apr 2013 04:32am EDT 

Medistim ASA announced that the Annual General Meeting of the Company approved, in accordance with the Board's proposal, a dividend of NOK 1.10 per share to be paid for the fiscal year 2012. Shareholders registered in VPS by the end of April 25, 2013 will have the right to the dividend. The Medistim shares will be traded as ex dividend NOK 1.10 as of April 26, 2013.  Full Article

Medistim ASA Proposes FY 2012 Dividend of NOK 1.1 per Share
Thursday, 28 Feb 2013 02:02am EST 

Medistim ASA announced that the Board proposes to the Annual General Meeting a dividend of NOK 1.1 per share for the fiscal year 2012. In the fiscal year 2011, a dividend of NOK 1.0 per share was reported.  Full Article

BRIEF-Medistim Q3 EBIT up 54.1 pct to NOK 10.0 mln

* Q3 sales 52.0 million Norwegian crowns versus 44.3 million crowns

Search Stocks